Cargando…
Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY‐876
Despite the long‐known fact that the facilitative glucose transporter GLUT1 is one of the key players safeguarding the increase in glucose consumption of many tumor entities even under conditions of normal oxygen supply (known as the Warburg effect), only few endeavors have been undertaken to find a...
Autores principales: | Siebeneicher, Holger, Cleve, Arwed, Rehwinkel, Hartmut, Neuhaus, Roland, Heisler, Iring, Müller, Thomas, Bauser, Marcus, Buchmann, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095872/ https://www.ncbi.nlm.nih.gov/pubmed/27552707 http://dx.doi.org/10.1002/cmdc.201600276 |
Ejemplares similares
-
Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies
por: Möller, Carsten, et al.
Publicado: (2018) -
BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients
por: Sugawara, Tatsuo, et al.
Publicado: (2016) -
Structural Evidence for Isoform-Selective Allosteric
Inhibition of Lactate Dehydrogenase A
por: Friberg, Anders, et al.
Publicado: (2020) -
Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876
por: Ma, Yibao, et al.
Publicado: (2018) -
BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I
por: Ellinghaus, Peter, et al.
Publicado: (2013)